BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36354726)

  • 1. Impact of Age of Onset on Survival after Hepatectomy for Patients with Colorectal Cancer Liver Metastasis: A Real-World Single-Center Experience.
    Wang HW; Wang LJ; Jin KM; Bao Q; Li J; Ge SK; Wang K; Xing BC
    Curr Oncol; 2022 Nov; 29(11):8456-8467. PubMed ID: 36354726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic significance of clinicopathological characteristics in early-onset versus late-onset colorectal cancer liver metastases.
    Li YT; Wang XY; Zhang B; Tao BR; Chen ZM; Ma XC; Han JH; Zhang C; Zhang R; Chen JH
    Int J Colorectal Dis; 2023 Jan; 38(1):19. PubMed ID: 36658235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of the combination of primary tumor location and RAS mutational status on patients with colorectal liver metastasis undergoing hepatectomy.
    Yan XL; Wang K; Bao Q; Wang HW; Jin KM; Su YM; Xing BC
    J Surg Oncol; 2022 May; 125(6):1002-1012. PubMed ID: 35171534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer.
    Margonis GA; Buettner S; Andreatos N; Kim Y; Wagner D; Sasaki K; Beer A; Schwarz C; Løes IM; Smolle M; Kamphues C; He J; Pawlik TM; Kaczirek K; Poultsides G; Lønning PE; Cameron JL; Burkhart RA; Gerger A; Aucejo FN; Kreis ME; Wolfgang CL; Weiss MJ
    JAMA Surg; 2018 Jul; 153(7):e180996. PubMed ID: 29799910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.
    Margonis GA; Kim Y; Sasaki K; Samaha M; Amini N; Pawlik TM
    Cancer; 2016 Sep; 122(17):2698-707. PubMed ID: 27244540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.
    Tsilimigras DI; Ntanasis-Stathopoulos I; Bagante F; Moris D; Cloyd J; Spartalis E; Pawlik TM
    Surg Oncol; 2018 Jun; 27(2):280-288. PubMed ID: 29937183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
    Bao Q; Wang K; Wang HW; Jin KM; Xing BC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
    [No Abstract]   [Full Text] [Related]  

  • 8. RAS Mutation is Associated with Unsalvageable Recurrence Following Hepatectomy for Colorectal Cancer Liver Metastases.
    Okuno M; Goumard C; Kopetz S; Vega EA; Joechle K; Mizuno T; Omichi K; Tzeng CD; Chun YS; Vauthey JN; Conrad C
    Ann Surg Oncol; 2018 Aug; 25(8):2457-2466. PubMed ID: 29786130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAS mutation status in combination with the JSHBPS nomogram may be useful for preoperative identification of colorectal liver metastases with high risk of recurrence and mortality after hepatectomy.
    Takematsu T; Mima K; Hayashi H; Kitano Y; Nakagawa S; Hiyoshi Y; Okabe H; Imai K; Miyamoto Y; Baba H
    J Hepatobiliary Pancreat Sci; 2024 Feb; 31(2):69-79. PubMed ID: 37897144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of primary tumour location in patients undergoing hepatic resection for colorectal liver metastasis.
    Wang K; Xu D; Yan XL; Poston G; Xing BC
    Eur J Surg Oncol; 2018 Jun; 44(6):771-777. PubMed ID: 29580735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resection of Colorectal Liver Metastasis: Prognostic Impact of Tumor Burden vs KRAS Mutational Status.
    Tsilimigras DI; Hyer JM; Bagante F; Guglielmi A; Ruzzenente A; Alexandrescu S; Poultsides G; Sasaki K; Aucejo F; Pawlik TM
    J Am Coll Surg; 2021 Apr; 232(4):590-598. PubMed ID: 33383214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic impact of RAS on overall survival following liver resection in early versus late-onset colorectal cancer patients.
    Jácome AA; Vreeland TJ; Johnson B; Kawaguchi Y; Wei SH; Nancy You Y; Vilar E; Vauthey JN; Eng C
    Br J Cancer; 2021 Feb; 124(4):797-804. PubMed ID: 33208919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sub-millimeter surgical margin is acceptable in patients with good tumor biology after liver resection for colorectal liver metastases.
    Xu D; Wang HW; Yan XL; Li J; Wang K; Xing BC
    Eur J Surg Oncol; 2019 Sep; 45(9):1551-1558. PubMed ID: 30879931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of genomic profiles and survival in early onset and screening-age colorectal cancer patients with liver metastases resected over 15 years.
    Narayan RR; Aveson VG; Chou JF; Walch HS; Sanchez-Vega F; Santos Fernandes GD; Balachandran VP; D'Angelica MI; Drebin JA; Jarnagin WR; Wei AC; Cercek A; Gönen M; Schultz N; Kingham TP
    J Surg Oncol; 2022 Apr; 125(5):880-888. PubMed ID: 35066881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contour prognostic model for predicting survival after resection of colorectal liver metastases: development and multicentre validation study using largest diameter and number of metastases with RAS mutation status.
    Kawaguchi Y; Kopetz S; Tran Cao HS; Panettieri E; De Bellis M; Nishioka Y; Hwang H; Wang X; Tzeng CD; Chun YS; Aloia TA; Hasegawa K; Guglielmi A; Giuliante F; Vauthey JN
    Br J Surg; 2021 Aug; 108(8):968-975. PubMed ID: 33829254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Specific Mutations in KRAS Codon 12 and Colorectal Liver Metastasis.
    Margonis GA; Kim Y; Spolverato G; Ejaz A; Gupta R; Cosgrove D; Anders R; Karagkounis G; Choti MA; Pawlik TM
    JAMA Surg; 2015 Aug; 150(8):722-9. PubMed ID: 26038887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.
    Vauthey JN; Zimmitti G; Kopetz SE; Shindoh J; Chen SS; Andreou A; Curley SA; Aloia TA; Maru DM
    Ann Surg; 2013 Oct; 258(4):619-26; discussion 626-7. PubMed ID: 24018645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of KRAS Mutation on Long-Term Outcomes of Patients Undergoing Hepatic Resection for Colorectal Liver Metastases.
    Margonis GA; Spolverato G; Kim Y; Karagkounis G; Choti MA; Pawlik TM
    Ann Surg Oncol; 2015 Dec; 22(13):4158-65. PubMed ID: 26077912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditional Survival After Hepatectomy for Colorectal Liver Metastasis: Results from the Colorectal Liver Operative Metastasis International Collaborative (COLOMIC).
    Valenzuela CD; Moaven O; Solsky IB; Stauffer JA; Del Piccolo NR; Cheung T; Corvera CU; Wisneski AD; Cha CH; Pourhabibi Zarandi N; Dourado J; Perry KC; Russell G; Shen P
    Ann Surg Oncol; 2023 Jun; 30(6):3413-3422. PubMed ID: 36859704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Implication of KRAS Status after Hepatectomy for Colorectal Liver Metastases Varies According to Primary Colorectal Tumor Location.
    Sasaki K; Margonis GA; Wilson A; Kim Y; Buettner S; Andreatos N; Gani F; Amini N; Spolverato G; Pawlik TM
    Ann Surg Oncol; 2016 Oct; 23(11):3736-3743. PubMed ID: 27352204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.